Skip to main content
. 2022 Apr 12;9(6):795–809. doi: 10.1002/acn3.51559

Figure 2.

Figure 2

Effect of melatonin on gross cerebral infarct size, neurobehavioural outcome and cell death (A). Further stratified subgroup analysis to assess the efficacy of melatonin as a single therapy or as an adjunct agent with HT on combined neurological outcome (B). Forest plots of SMD with 95% CI ordered by effect size. Pooled estimate of effect size calculated using random effects model. SMD, standardised mean difference; HT, hypothermia.